A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 247.74
GOOG 1.110.71
MSFT 149.70
FB 156.79
BAC 21.60

Recently Added

CLOU 14.69
SEDG 82.37
CLVS 7.13
CODX 9.15
RLLCF 0.00

Gaining Speed

SEDG 82.37
CODX 9.15
CLVS 7.13
CLOU 14.69
ADXS 0.56

Advaxis (ADXS) Reports Updated Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC

Advaxis, Inc. (NASDAQ: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today announced updated results from the combination arms of the Company’s ongoing Phase 1/2 study investigating ADXS-503 in patients with non-small cell lung cancer (NSCLC) at the Immuno-oncology 360°...

Read More




Get Alerted When News Hits On This Stock - FREE!